Insider Transactions

What Septerna, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	10	29
Total trades	16	50

Shares traded

	3 months	12 months
Acquired	182,867	309,814
Disposed	1,528,667	1,659,115
Net activity	−1,345,800	−1,349,301

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Bhatt Elizabeth	President and COO	Oct 15	Open-market sale · S	−2,906	$37.61	−$109K	174,209
Bhatt Elizabeth	President and COO	Oct 15	Open-market sale · S	−1,094	$36.87	−$40.3K	177,115
Bhatt Elizabeth	President and COO	Oct 15	Exercise / conversion · M	+4,000	$6.81	+$27.2K	178,209
Long Daniel D.	SVP, Drug Discovery	Sep 01	Open-market sale · S	−3,333	$37.83	−$126K	96,412
Long Daniel D.	SVP, Drug Discovery	Sep 01	Exercise / conversion · M	+3,333	$2.76	+$9.2K	99,745
Third Rock Ventures V, L.p.	10% owner	Aug 12	Open-market sale · S	+141	$51.08	+$7.2K	6,068,391
Third Rock Ventures V, L.p.	10% owner	Aug 12	Open-market sale · S	+147,059	$50.27	+$7.39M	6,068,532
Ra Capital MANAGEMENT, L.p.	Director	Aug 12	Open-market sale · S	−746,500	$42.50	−$31.7M	725,443
Ra Capital MANAGEMENT, L.p.	Director	Aug 12	Open-market sale · S	−746,500	$42.50	−$31.7M	4,777,415
Bhatt Elizabeth	President and COO	Aug 11	Open-market sale · S	−25,000	$44.00	−$1.1M	174,209
Bhatt Elizabeth	President and COO	Aug 11	Exercise / conversion · M	+6,319	$2.76	+$17.4K	199,209
Bhatt Elizabeth	President and COO	Aug 11	Exercise / conversion · M	+18,681	$6.81	+$127K	192,890
Long Daniel D.	SVP, Drug Discovery	Aug 03	Open-market sale · S	−2,334	$34.68	−$80.9K	96,412
Long Daniel D.	SVP, Drug Discovery	Aug 03	Open-market sale · S	−1,000	$33.98	−$34K	98,746
Long Daniel D.	SVP, Drug Discovery	Aug 03	Exercise / conversion · M	+1,518	$2.76	+$4.19K	99,746
Long Daniel D.	SVP, Drug Discovery	Aug 03	Exercise / conversion · M	+1,816	$2.76	+$5.01K	98,228
Bhatt Elizabeth	President and COO	Jul 15	Open-market sale · S	−4,000	$33.99	−$136K	174,209
Bhatt Elizabeth	President and COO	Jul 15	Exercise / conversion · M	+4,000	$6.81	+$27.2K	178,209
Long Daniel D.	SVP, Drug Discovery	Jul 01	Open-market sale · S	−1,233	$34.81	−$42.9K	96,412
Long Daniel D.	SVP, Drug Discovery	Jul 01	Open-market sale · S	−2,100	$34.10	−$71.6K	97,645

Page 1 of 4 · showing the 20 most recent Sign up free to view all 78 transactions and filter by insider →

Comments